Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vascular Malformations 1Neoplasms 1Esophageal Neoplasms 1Anastomotic Leak 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Bioseal × Clear all
NCT03529266 2021-08-24

PLACE020

Sun Yat-sen University

Phase 2 Completed
57 enrolled
Gastrointestinal

Esophageal Neoplasms, Anastomotic Leak

NCT03110783 2019-11-18

Bioseal Dural Sealing Study BIOS-14-001

Guangzhou Bioseal Biotechnology Co., Ltd.

Phase 3 Completed
200 enrolled

Neoplasms, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡